RecruitingNCT06305741
This study is recruiting in the United States. It is testing an Anxiety Intervention for anxiety.
In United StatesAnxietyBehavioralOver 40 Years
- Countries
- United States
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Condition
- Anxiety
RecruitingNCT07286175
This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for Bipolarity.
In United StatesBipolarityDrugA study involving a medication or substance.From 18 Years to 75 Years
- Countries
- United States, Argentina, Brazil, ...
- Sponsor
- Eli Lilly and Company
- Condition
- Bipolarity
RecruitingNCT07412756
This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.
In United StatesDepressionDrugFrom 18 Years to 75 Years
- Countries
- United States, Australia, Canada, ...
- Sponsor
- Eli Lilly and Company
- Condition
- Depression
RecruitingNCT07410507
This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 55 Years
- Countries
- United States, Argentina, Brazil, ...
- Sponsor
- Eli Lilly and Company
- Condition
- Schizophrenia
RecruitingNCT05803551
This study is recruiting in the United States. It focuses on Depression.
In United StatesDepressionDrugFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
RecruitingNCT07323784
This study is recruiting in the United States. It is testing NTX-1472 for anxiety.
In United StatesAnxietyDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Newleos Therapeutics, Inc.
- Condition
- Anxiety
RecruitingNCT07573176
This study is recruiting in the United States. It is testing seltorexant for depression.
In United StatesDepressionDrugFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Depression
RecruitingNCT07615426
This study is recruiting in the United States. It is testing aticaprant for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
RecruitingNCT06696755
This study is recruiting in the United States. It is testing adverse Events and Change for Bipolarity.
In United StatesBipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Bipolarity
RecruitingNCT07145918
This study is recruiting in the United States. It is testing adverse Events, Change for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Schizophrenia
RecruitingNCT04777357
This study is recruiting in the United States and in Russian Federation. It is testing change for depression.
In United StatesBipolarity, DepressionDrugFrom 10 Years to 17 Years
- Countries
- United States, Russian Federation
- Sponsor
- AbbVie
- Condition
- Bipolarity, Depression
RecruitingNCT07276997
This study is recruiting in the United States. It is testing change for depression.
In United StatesDepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Depression
